The Marzetti Company (NASDAQ:MZTI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

The Marzetti Company (MZTI) reported Q2 CY2026 sales of $465M, down 2.2% YoY, missing estimates. Non-GAAP EPS of $1.46 beat expectations by 4.1%. Analysts project 7% revenue growth over the next 12 months, above sector average.

Original reporting
Published Aug 25, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 1:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Marzetti Company (NASDAQ:MZTI) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$MZTINeutralMed
01

Why it matters

Earnings miss on revenue may pressure the stock, but EPS beat could cushion downside.

02

Market read

Earnings release provides fresh data for traders evaluating small‑cap consumer staples.

03

What to watch

Potential upside from new product launches and AI‑driven efficiencies not reflected in current numbers.

Relevance 7/10Novelty 7/10Timing: post‑earnings today

Background

The Marzetti Company is a specialty food producer known for frozen breads and dressings.

Company-level read

Ticker impact

$MZTINeutralMedium confidence
Context

Q2 CY2026 earnings report shows revenue miss and EPS beat, providing fresh financial data.

Expected impact

stock likely to remain flat or see modest downside after earnings.

Evidence & confidence

Mixed results (miss on sales, beat on EPS) typically limit upside; no guidance change reported.

Market effects

Consumer staples sector may see modest pressure from weaker sales trends.

U.S. small‑cap consumer staples could face slight valuation adjustments.

Limited global impact; primarily affects U.S. investors in the niche.

Counterpoint

Despite revenue miss, the EPS beat and stable margins could support a short‑term bounce.

Key entities

  • The Marzetti Company

    Specialty food producer reporting Q2 CY2026 results.

Related articles

$MZTIHigh

Marzetti’s (MZTI) Record Streak Hits a Wall With Outbreak and Guidance Cut

Marzetti (MZTI) reported a 2.2% sales decline to $465.0M in Q4, but adjusted sales grew. Fiscal 2026 saw record net sales, gross profit, and operating income. Gross margin expanded 220 bps to 24.5%. A Cyclospora outbreak may cut Q1 sales by 250 bps, leading to a 15% drop in operating income. The company acquired Bachan's, which added $15.4M in sales.

Med

Marzetti (MZTI) Q4 2026 Earnings Call Transcript

Marzetti (MZTI) reported Q4 2026 net sales of $465M, down 2.2% YoY. Adjusted net sales rose 0.4%, driven by a 0.9% increase in retail sales, including $15.4M from Bachan's. Gross profit and operating income reached record highs, up 7.4% and 48.2% respectively. The company also reported record annual operating cash flow of $283.8M. The company increased its dividend by 5% and completed $36.3M in share buybacks.

$MZTIMedAI 8/10

The Dividend King Investors May Have Overlooked

The Marzetti Company (MZTI) has increased its dividend for 63 consecutive years, with the latest quarterly dividend at $1.00 per share. Fiscal 2026 saw record operating cash flow of $283.8 million, with dividends consuming 38% of it. Net income rose to $191.6 million, and gross margin expanded to 24.5%. The company rebranded in 2025, aligning with its food brands.

$MZTIMed

MZTI Q2 Deep Dive: Margin Expansion and New Product Launches Offset Sales Decline

The Marzetti Company (MZTI) reported Q2 CY2026 sales of $465M, down 2.2% YoY, missing expectations. Non-GAAP EPS of $1.46 beat estimates by 4.1%. Management cited lower sales volumes and the exit of a supply agreement for the decline, but attributed higher margins to productivity initiatives and the Bachan’s acquisition. The company expects growth from Bachan’s integration, new products, and pricing actions.

$MZTIMedAI 8/10

The Marzetti Co (MZTI) (Q4 2026) Earnings Call Highlights: Record Year Fueled

The Marzetti Co (MZTI) reported a 2.2% decline in Q4 net sales due to reduced club channel sales and pipeline build comparisons. A Cyclospora outbreak is expected to cause a 250 basis point net sales headwind in Q1 2027. Core retail business, excluding Bachan's, saw a 7% organic volume decline. Commodity inflation is forecasted at 5% for fiscal 2027. The company expects 100 basis points of gross margin growth in fiscal 2027, driven by Bachan's integration and cost savings. CEO Dave Ciesinski ant

$MZTIHigh

MARZETTI CO (MZTI): Results of Operations and Financial Condition

MARZETTI CO (MZTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SYMBOL: MZTI August 25, 2026 TRADED: Nasdaq THE MARZETTI COMPANY REPORTS FOURTH QUARTER AND FISCAL YEAR RESULTS WESTERVILLE , Ohio, August 25 - The Marzetti Company (Nasdaq: MZTI) reported results today for the company’s fiscal fourth quarter an